Biohaven Pharmaceutical Holding (BHVN) PT Raised to $115 at Cantor Fitzgerald

December 29, 2020 8:03 AM EST
Get Alerts BHVN Hot Sheet
Price: $94.86 -5.52%

Rating Summary:
    11 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 8 | New: 61
Trade Now! 
Join SI Premium – FREE
Cantor Fitzgerald analyst Charles Duncan raised the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $115.00 (from $109.00) while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change